Characteristics of nosologically informative data sets that address key diagnostic issues facing the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V) and International Classification of Diseases, eleventh edition (ICD-11) substance use disorders workgroups

Addiction

Volumn 101, Issue SUPPL. 1, 2006, Pages 161-169

  Cottler, Linda B ^a   Grant, Bridget F ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Diagnostic issues; DSM; ICD; Nomenclature; Nosology; Substance use disorders

Indexed keywords

ALGORITHM; ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; PSYCHIATRIC DIAGNOSIS; SCORING SYSTEM; SUBSTANCE ABUSE;

ALGORITHMS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; SUBSTANCE-RELATED DISORDERS; TERMINOLOGY; TERMINOLOGY AS TOPIC;

EID: 33746863255     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2006.01590.x     Document Type: Article

References (35)

1. Cottler L. B., Schuckit M. A., Helzer J. E., Crowley T., Woody G., Nathan P. et al. The DSM IV field trial for substance use disorders: major results. Drug Alcohol Depend 1995; 38: 59-69.
2. Saunders J., Schuckit M. A. The development of a research agenda for substance use disorders diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, fifth Edition (DSM-V). Addiction 2006; 101 (Suppl. 1): 1-5.
3. Schuckit M. A., Saunders J. The empirical basis of substance use disorders diagnosis: research recommendations for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V). Addiction 2006; 101 (Suppl. 1): 170-3.
4. Hasin D. Substance use disorders in DSM-IV and ICD-10. Addiction 2006; 101 (Suppl. 1): 59-75.
5. Helzer J. Should there be both clinical (categorical) and research (dimensional) criteria for the substance use disorders in DSM-V? Addiction 2006; 101 (Suppl. 1): 17-22.
6. Grant B. F., Moore T. C., Kaplan K. Source and Accuracy Statement. Wave 1. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism. Available at http://www.niaaa.nih.gov.
7. Demyttenaere K., Bruffaerts R., Posada-Villa J., Gasquet I., Kovess V., Lepine J. P. et al. for the WHO World Mental Health Survey Consortium. Prevalence, severity and unmet need for treatment of mental disorders in the World Mental Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-90.
8. Kessler R. C., Ustun T. B. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Meth Psychiatr Res 2004; 13: 93-121.
9. Kessler R. C., McGonagle K. A., Zhao S., Nelson C., Hughes M., Eshleman S. et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
10. Insel T. R., Fenton W. S. Psychiatric epidemiology. It's not just about counting anymore. Arch Gen Psychiatry 2005; 62: 590-2.
11. Hasin D. S., Grant B. F. The co-occurrence of DSM-IV alcohol abuse and DSM-IV alcohol dependence. results from the National Epidemiologic Survey on Alcohol and Related Conditions on heterogeneity that differ by population subgroup. Arch Gen Psychiatry 2004; 61: 891-6.
12. Hasin D. S., Hatzenbueler M., Smith S., Grant B. F. Co-occurring DSM-IV drug abuse in DSM-IV drug dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2005; 80: 117-23.
13. Muthén B. Should substance use disorders be considered as categorical or dimensional? Addiction 2006; 101 (Suppl. 1): 6-16.
14. Hasin D. S., Schuckit M. A., Martin C. S., Grant B. F., Bucholz K. K., Helzer J. E. The validity of DSM-IV alcohol dependence: what do we know and what do we need to know? Alcohol Clin Exp Res 2003; 27: 244-52.
15. Schuckit M. A., Smith T. L., Danko G. P. et al. Prospective evaluation of the four DSM-IV criteria for alcohol abuse in a large population. Am J Psychiatry 2005; 16: 350-60.
16. Budney A. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? Addiction 2006; 101 (Suppl. 1): 125-33.
17. Crowley T. Adolescents and substance related disorders: research agenda to guide decisions on DSM-V. Addiction 2006; 101 (Suppl. 1): 115-24.
18. Hughes J. Drug-specific versus generic criteria for dependence: the case of nicotine dependence. Addiction 2006; 101 (Suppl. 1): 134-41.
19. Langenbucher J. W., Morgenstern J., Miller K. DSM-III, DSM-IV and ICD-10 as severity scales for drug dependence. Drug Alcohol Depend 1995; 39: 139-50.
20. Cottler L. B. Comparing DSM-III-R and ICD-10 substance use disorders. Addiction 1993; 88: 689-96.
21. Sarr M., Bucholz K. K., Phelps D. L. Using cluster analysis of alcohol use disorders to investigate 'diagnostic orphans': subjects with alcohol dependence symptoms but no diagnosis. Drug Alcohol Depend 2000; 60: 295-302.
22. Hasin D., Paykin A. Dependence symptoms but no diagnosis: diagnostic 'orphans' in a 1992 national sample. Drug Alcohol Depend 1999; 53: 215-22.
23. Grant B. The DSM-IV field trial for substance use disorders: major results. [Brief commentary]. Drug Alcohol Depend 1995; 38: 71-5.
24. Robins L., Cottler L. B. Making a structured psychiatric diagnostic interview faithful to the nomenclature. Am J Epidemiol 2004; 160: 808-13.
25. Rounsaville B., Petry N., Carroll K. Single vs. multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend 2003; 70: 117-25.
26. Alterman A. I., Cacciolo J., Mulvaney F., Rutherford M., Langenbucher J. Alcohol dependence and abuse in three groups at varying familial alcoholism risk. J Consult Clin Psychol 2002; 70: 336-42.
27. Glowinski A., Madden P., Bucholz K., Lynskey M., Heath A. Genetic epidemiology of self-reported lifetime DSM-IV major depressive disorder in a population based twin sample of female adolescents. J Child Psychol Psychiatry 2003; 44: 988-96.
28. Babor T. Subtypes of dependence and abuse. Addiction 2006; 101 (Suppl. 1): 104-10.
29. Beseler C., Jacobson K. C., Kremen W. S., Lyons M. J., Glatt S., Faraone S. V. et al. Is there heterogeneity among syndromes of substance use disorder for illicit drugs? J Addict Dis 2006; 31: 929-47.
30. Cottler L. B., Womack S. B., Compton W. M., Ben-Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum Psychopharmacol 2001; 16: 599-606.
31. Cottler L. B., Hoffer L. The Club Drug Study: St. Louis, Miami, and Sydney, Australia - (CD-SLAM). National Institute on Drug Abuse (NIDA) Epidemiology Trends in Drug Abuse. Proceedings of the Community Epidemiology Work Group, II. Bethesda, MD: NIDA; 2003, p. 341-343.
32. Cottler L. B., Compton W. M., Brown L., Shell A., Keating S., Shillington A. et al. The Discrepancy Interview Protocol: a method for evaluating and interpreting discordant survey responses. Int J Meth Psychiatr Res 1994; 4: 1994.
33. Moher D., Schulz K. F., Altman D. and CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY) 2005; 1: 40-5.
34. Babor T., Lauerman R. J., Cooney N. L. In search of the alcohol dependance syndrome: A cross national study of its structure and validity. In: Paakkanen P. & Sulkunen P., eds. Cultural Studies on Drinking and Drinking Problems, Report on a Conference, No. 176, 1987.
35. Gordis L. Assuring the quality of questionnaire data in epidemiologic research. Am J Epidemiol 1979; 109: 21-4.